0 NYSE Companies - December 3, 2018FTI Consulting Appoints Veteran Political and Analytics Expert to Lead Its Digital & Insights OfferingsWASHINGTON, Dec. 03, 2018 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE:FCN) today announced the appointment of Brent McGoldrick as a […]Read More
0 NYSE Companies - December 3, 2018Gold Resource Corporation Expands Arista Mine Drilling 16.95 Meters of 6.21 g/t Gold and Discovers New Mineralized Southwest VeinsCOLORADO SPRINGS, Colo., Dec. 03, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Gold Resource Corporation (NYSE American: GORO) (the “Company”) […]Read More
0 NASDAQ Companies - December 3, 2018Cytori Announces Japan Class III Medical Device Approval for Cell Therapy ProductExpands medical device production capabilities SAN DIEGO and TOKYO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” […]Read More
0 NASDAQ Companies - December 3, 2018Xenon Announces Final Results of XEN1101 Phase 1 Clinical Trial and Update on XEN901 Phase 1 Clinical Trial at the American Epilepsy Society (AES) Annual MeetingXEN1101 CTA Accepted by Health Canada for Initiation of Phase 2 Clinical Trial in Adult Focal Epilepsy;U.S. IND Filing Targeted […]Read More
0 NASDAQ Companies - December 3, 2018TG Therapeutics, Inc. Announces Oral Presentation of Follow-Up Data from the Triple Combination of Ublituximab, Umbralisib, and Pembrolizumab in Patients with Relapsed/Refractory CLL and Richter’s Transformation at 60th American Society of Hematology Annual Meeting and ExpositionNEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced updated clinical data from its […]Read More
0 NASDAQ Companies - December 3, 2018Lincoln Electric Announces Acquisition of Inovatech Engineering CorporationAdvances Lincoln Electric’s Automation Strategy CLEVELAND, Dec. 03, 2018 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc. (the “Company”) (Nasdaq: LECO) […]Read More
0 NASDAQ Companies - December 3, 2018Onconova Highlights Results from Phase 2 Trial of Oral Rigosertib In Combination with Azacitidine (Vidaza®) in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual MeetingOverall response rate (ORR) of 90% reported in this multi-institutional Phase 2 study in hypomethylating agent (HMA) naïve patients, including […]Read More
0 TSX News - December 3, 2018Goodfood Achieves Record Quarterly Subscriber Growth With 37,000 Net Additions in Q1 2019Active Subscribers Count Reaches 126,000; An Increase of 42% Quarter Over Quarter MONTREAL, Dec. 03, 2018 (GLOBE NEWSWIRE) — Goodfood […]Read More
0 TSX News - December 3, 2018Theratechnologies Appoints New Chief Commercial OfficerMONTREAL, Dec. 03, 2018 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce the appointment of Mr. […]Read More
0 TSX Venture News - December 3, 2018Datametrex Announces Voting Results From the 2018 Annual and Special Meeting of ShareholdersTORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) — DatametrexAI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased to […]Read More